Compare ELV & CRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ELV | CRH |
|---|---|---|
| Founded | 1944 | 1936 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Building Materials |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 76.6B | 83.3B |
| IPO Year | N/A | N/A |
| Metric | ELV | CRH |
|---|---|---|
| Price | $374.99 | $124.81 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 18 | 14 |
| Target Price | ★ $392.06 | $131.71 |
| AVG Volume (30 Days) | 1.4M | ★ 12.1M |
| Earning Date | 01-28-2026 | 02-25-2026 |
| Dividend Yield | ★ 1.86% | 1.20% |
| EPS Growth | N/A | ★ 0.53 |
| EPS | ★ 24.39 | 5.01 |
| Revenue | ★ $194,820,000,000.00 | $36,901,000,000.00 |
| Revenue This Year | $13.22 | $6.72 |
| Revenue Next Year | $3.49 | $5.99 |
| P/E Ratio | ★ $15.04 | $24.55 |
| Revenue Growth | ★ 11.96 | 4.28 |
| 52 Week Low | $273.71 | $76.75 |
| 52 Week High | $458.75 | $129.75 |
| Indicator | ELV | CRH |
|---|---|---|
| Relative Strength Index (RSI) | 70.56 | 50.28 |
| Support Level | $345.01 | $124.77 |
| Resistance Level | $375.19 | $129.75 |
| Average True Range (ATR) | 7.62 | 2.53 |
| MACD | 2.26 | -0.64 |
| Stochastic Oscillator | 88.78 | 32.81 |
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 46 million medical members as of June 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
CRH is a global manufacturer of a range of building products used in construction projects, operating via a vertically integrated business model. The past decade has seen CRH transform into a leading building materials business, with increasing exposure to upstream building activities such as aggregates and cement. CRH's geographic footprint is mostly across developed markets. North America is CRH's largest market and accounts for 75% of EBITDA. The company is the largest producer of aggregates and asphalt in the US.